Mani, Inc. (MNICF) fair value: what the stock is really worth
As of Sep 18, 2026: fair value of Mani, Inc. $6.44, price $12.82, upside -49.8%, quality 64 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Mani, Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
24‑month range $12.22 – $12.82 · fair‑value band $3.97 – $8.17 · the $12.82 price screens above the $6.44 fair value. Dashed = 300-day average. As of Sep 23, 2026.
Follow Mani in your weekly email
Every Wednesday you see whether Mani is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products.
Show more
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.
Stock analysis
Mani, Inc. (MNICF) currently trades at $12.82, while our model-based Fair Value estimate is $6.44, implying the stock looks roughly 99.1% overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of $6.53 per share, and 0 of the 24 models we run sit above the $12.82 price.
Bear case: the Growth DCF group reads lowest at $1.59, and 24 of the 24 models stay below the price. Evidence for this calculation is high.
Scenario range: $3.97 (bear) to $8.17 (bull), the price of $12.82 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Mani, Inc. reported revenue of ¥30.0B in FY2025 versus ¥17.2B in FY2021, a compound +14.9%/yr. Reported net income was ¥4.6B in FY2025, compounding +2.0%/yr from FY2021.
Key figures
Market cap $1.3B · P/E ratio 30.5 · P/S ratio 4.73 · EPS (TTM) $0.4200 · Dividend yield 2.4% · Net margin 15.5% · Return on equity 10.2% · Return on assets (EBIT) 13.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 1% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at −50%, MNICF screens richer than that median.
Fair Value models
Bear $3.97Fair Value $6.44Bull $8.17
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+5.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.5%
Start year 2020 (pandemic)
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in JPY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in JPY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+6.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.0%
Dividend (yield on the price)2.4%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.29% → 27%
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+79.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+9.0%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about +75.7% a year for the price and +6.8% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 203 stocks
Beats the industry median on 8/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score64 · Above median
Fair Value upside−50% · Below median
Profitability
Return on equity (TTM)10% · Above median
Return on assets10% · Top 25%
Net margin (TTM)18% · Top 25%
Operating margin (TTM)34% · Top 25%
Growth and dividend
Revenue growth16% · Top 25%
Dividend yield (TTM)2.4% · Above median
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
P/E (TTM)30.5× · Pricier than median
P/B3.74× · Priciest 25%
P/S (TTM)6.41× · Priciest 25%
P/FCF3.6× · Cheaper than median
EV/EBITDA15.7× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 15
FUTURE (revenue growth)79· sector 31
PAST (return on equity)41· sector 25
HEALTH (low debt)0· sector 96
DIVIDEND (yield)48· sector 33
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Mani, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/MNICF
Frequently asked questions
Is Mani, Inc. (MNICF) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $6.44 versus a price of $12.82, about −50% upside (overvalued).
What is the fair value of MNICF?
Our model-based fair value for Mani, Inc. is $6.44 (as of Sep 23, 2026), built from audited fundamentals. The current price: $12.82.
What is the quality score of MNICF?
Mani, Inc. has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Mani, Inc. (MNICF)?
Our model-based price target is the fair value of $6.44 (as of Sep 23, 2026) from 24 valuation models. Cautious scenario $3.97, optimistic scenario $8.17. It is a calculation from audited fundamentals, not an analyst target.
What is the Mani, Inc. stock forecast for 2026?
Our models put fair value at $6.44, about −50% upside versus a price of $12.82 (overvalued). Cautious scenario $3.97, optimistic scenario $8.17. The calculation is refreshed regularly with new filings.
What is the revenue of Mani, Inc. (MNICF)?
Mani, Inc. reported trailing-twelve-month revenue of about ¥31.3B (latest available figure, as of Sep 23, 2026).
Does Mani, Inc. pay a dividend?
Mani, Inc. currently shows a dividend yield of about 2.41% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Mani, Inc. (MNICF)?
For today's price to be fair in a discounted-cash-flow model, Mani, Inc. would have to grow free cash flow by +79.4 % per year for five years (discount rate 9.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +14.5 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of MNICF use?
Our models discount Mani, Inc. at 9.8 %: a base by market capitalisation (small), damped by beta 0.38, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Mani, Inc. that is +79.4 % per year a year over ten years, using the same discount rate (9.8 %) and the same formula as our fair value.
How much growth has Mani, Inc. (MNICF) delivered so far?
Over the past 5 years revenue at Mani, Inc. grew +14.5 % a year. The price currently implies +79.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Mani, Inc. (MNICF) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into Mani, Inc. (+79.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Mani, Inc. (MNICF)?
The free-cash-flow yield on the price is 0.17 %: that much free cash flow Mani, Inc. produces per unit of market value. When it exceeds the discount rate of our models (9.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Mani, Inc. (MNICF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mani, Inc. it is $6.44 per share (as of Sep 23, 2026), against a price of $12.82. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Mani, Inc. stock overvalued or undervalued in 2026?
As of Sep 23, 2026, MNICF trades above its calculated fair value: price $12.82, fair value $6.44, a gap of about −50% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MNICF?
No. The price is what the market pays today ($12.82); the fair value is what the company's own numbers justify ($6.44). For Mani, Inc. the two are $6.38 per share apart. That gap is exactly why we show both numbers side by side.
How much is Mani, Inc. worth?
The market values Mani, Inc. at about $1.3B (market capitalisation, as of Sep 23, 2026). Per share that is $12.82; our models calculate a fair value of $6.44 per share.
What do the bullish and bearish scenarios say about MNICF?
Our models span a range for Mani, Inc.: cautious scenario $3.97, base $6.44, optimistic $8.17 per share (as of Sep 23, 2026, price $12.82). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MNICF?
Mani, Inc. trades at a price-to-earnings ratio of 30.5 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $6.44 is built from several models across several years. Other multiples: P/B 3.7, P/S 6.4, EV/EBITDA 15.7.
How solid is the balance sheet of Mani, Inc. (MNICF)?
Balance-sheet figures for Mani, Inc. (as of Sep 23, 2026): return on equity 10.2%. They feed the Quality Score of 64/100, which measures business quality independently of the share price.
How far is MNICF from its 52-week high?
Mani, Inc. trades at $12.82, at its 52-week high of $12.82 and 1% above the low of $12.71 (as of Sep 18, 2026). Distance from the high says nothing about value: that is what the fair value of $6.44 is for.
Which stocks are comparable to Mani, Inc.?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Mani, Inc. stock attractive at the current price?
The data as of Sep 23, 2026: price $12.82, calculated fair value $6.44 (−50%), Quality Score 64/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MNICF calculated?
We run Mani, Inc. through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $6.44, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Mani, Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Mani, Inc. (MNICF)?
The closing price on Sep 18, 2026 was $12.82. Our model-based fair value is $6.44, about −50% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Mani, Inc. right now?
The price sits above even our optimistic bull case ($8.17). The favourable scenario is already priced in. Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($3.97 to $8.17) leaves room in how you read the outcome.
Key figures of Mani, Inc.
How large is the market capitalisation of Mani, Inc. (MNICF)?
The market capitalisation of Mani, Inc. is $1.3B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Mani, Inc. (MNICF)?
The price-to-sales ratio of Mani, Inc. is 4.73 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Mani, Inc. (MNICF)?
Earnings per share at Mani, Inc. are $0.4200 (price ÷ EPS = P/E 30.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Mani, Inc. (MNICF)?
The dividend yield of Mani, Inc. is 2.4% (payout 73.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Mani, Inc. (MNICF)?
The net margin of Mani, Inc. is 15.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Mani, Inc. (MNICF)?
The return on equity (ROE) of Mani, Inc. is 10.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Mani, Inc. (MNICF)?
On an EBIT basis the return on assets of Mani, Inc. is 13.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Mani, Inc. (MNICF)?
The operating margin of Mani, Inc. is 34.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Mani, Inc. (MNICF)?
Revenue at Mani, Inc. is growing +15.7% versus a year earlier (3y avg +13.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Mani, Inc. (MNICF)?
Earnings per share at Mani, Inc. are growing +49.2% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Mani, Inc. in the live analysis
One click puts Mani, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Broad data
Sep 23, 2026